尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Meeker David P. Director active across 2 companies, notably Rhythm Pharmaceuticals, INC.. Cumulatively, 14 filings have been logged. Breakdown: 0 buy · 6 sells. Total volume traded: €6.1m. Activity tracked since 16 February 2024. The latest transaction was disclosed on 14 September 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 条申报中的 14 条
Meeker David P is a declarant linked to Rhythm Pharmaceuticals, INC. and Trevi Therapeutics, Inc., where he is President and CEO and Director. Across 8 filings in total, the 8 sampled filings run from 2024-02-05 to 2026-02-03, with EUR 0 in purchases and EUR 1640872 in sales, and the largest listed transaction is a sale of EUR 1640872.468566561 at Rhythm Pharmaceuticals, INC. on 2024-03-19.